Literature DB >> 28032714

N-acetylcysteine Attenuates Cobalt Nanoparticle-Induced Cytotoxic Effects through Inhibition of Cell Death, Reactive Oxygen Species-related Signaling and Cytokines Expression.

Ya-Ke Liu1, Hong-Wei Yang2, Meng-Hong Wang3, Wei Wang2, Fan Liu2, Hui-Lin Yang1.   

Abstract

OBJECTIVE: Complex cobalt-chromium alloys, bearing surfaces of the second-generation metal-on-metal (MoM) hip prostheses, are subject to wear and generate cobalt nanoparticles (CoNPs). CoNPs could reduce cellular viability, activate the mitogen-activated protein kinase (MAPK) pathway and increase cell apoptosis via reactive oxygen species (ROS). However, the detailed mechanisms of ROS functioning on CoNP-mediated signaling molecules and cytotoxicity has not yet been fully demonstrated. The present study investigated the functional role of N-acetylcysteine (NAC) in reversing the activation of ROS signaling pathways triggered by CoNPs in normal mice kidney cells (TCMK-1 cells).
METHODS: After being pretreated with NAC, TCMK-1 cells were treated with 300-700 μmol/L CoNPs, then, CCK-8 assay was used to verify the survival of TCMK-1 cells. Annexin V/PI staining was performed to investigate the apoptosis of TCMK-1 cells after NAC and different concentrations of CoNP treatments. In addition, western blot was performed to identify the cytokine (p-ERK, p-p38, and p-JNK) expression of the ROS-related MAPK signaling pathway.
RESULTS: Apoptosis rate of TCMK-1 cells was increased obviously after different concentrations of CoNP treatment. However, TCMK-1 cells, pretreated with NAC, exhibited a significantly decreased apoptosis rate. In addition, p-ERK, p-p38, and p-JNK expressions were increased with CoNP treatment, which indicated that CoNPs could activate the MAPK pathway. Interestingly, this entire stimulated phenomenon by CoNPs was reversed with NAC treatment.
CONCLUSIONS: These findings indicated that NAC could reverse CoNP-induced cytotoxicity by inhibiting ROS-induced cell death and cytokine expression. To our knowledge, this is the first report that describes how CoNP-induced cytotoxicity in TCMK-1 cells could be attenuated by anti-oxidative agents (NAC), which may function through inhibition of cell death and ROS.
© 2016 Chinese Orthopaedic Association and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  zzm321990N-acetylcysteine; Cobalt nanoparticle TCMK-1 cells; Cytotoxicity; Metal-on-metal hip prostheses

Mesh:

Substances:

Year:  2016        PMID: 28032714      PMCID: PMC6584440          DOI: 10.1111/os.12298

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  5 in total

Review 1.  The paradoxical role of tumor-infiltrating immune cells in lung cancer.

Authors:  Xiaodan Zheng; Yuhai Hu; Chengfang Yao
Journal:  Intractable Rare Dis Res       Date:  2017-11

2.  Intercellular transfer of mitochondria via tunneling nanotubes protects against cobalt nanoparticle-induced neurotoxicity and mitochondrial damage.

Authors:  Fuli Zheng; Zhousong Luo; Xinpei Lin; Wei Wang; Michael Aschner; Ping Cai; Yuan-Liang Wang; Wenya Shao; Guangxia Yu; Zhenkun Guo; Siying Wu; Huangyuan Li
Journal:  Nanotoxicology       Date:  2022-01-25       Impact factor: 5.881

3.  Melatonin counteracts cobalt nanoparticle‑induced cytotoxicity and genotoxicity by deactivating reactive oxygen species‑dependent mechanisms in the NRK cell line.

Authors:  Yake Liu; Xiaoyou Yang; Wei Wang; Xuefei Wu; Hai Zhu; Fan Liu
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

Review 4.  An Overview of the Beneficial Role of Antioxidants in the Treatment of Nanoparticle-Induced Toxicities.

Authors:  Vladimir Mihailovic; Jelena S Katanic Stankovic; Dragica Selakovic; Gvozden Rosic
Journal:  Oxid Med Cell Longev       Date:  2021-11-15       Impact factor: 6.543

5.  Alpha lipoic acid antagonizes cytotoxicity of cobalt nanoparticles by inhibiting ferroptosis-like cell death.

Authors:  Yake Liu; Wenfeng Zhu; Dalong Ni; Zihua Zhou; Jin-Hua Gu; Weinan Zhang; Huanjian Sun; Fan Liu
Journal:  J Nanobiotechnology       Date:  2020-10-02       Impact factor: 10.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.